-
公开(公告)号:US20100316722A1
公开(公告)日:2010-12-16
申请号:US12779556
申请日:2010-05-13
IPC分类号: A61K9/14 , A61K31/727 , A61K31/702 , A61P7/02
CPC分类号: A61K9/1635 , A61K9/1647 , A61K9/5138 , A61K9/5153
摘要: Pharmaceutical form containing at least an active compound and a polymeric matrix, wherein said polymeric matrix comprises at least one polymer of cationic nature and at least one biodegradable polymer, process for the preparation thereof, pharmaceutical formulations comprising said pharmaceutical form, and their uses. The pharmaceutical form provides enhanced absorption of active compounds across the mucosa.
摘要翻译: 含有至少一种活性化合物和聚合物基质的药物形式,其中所述聚合物基质包含至少一种具有阳离子性质的聚合物和至少一种可生物降解聚合物,其制备方法,包含所述药物形式的药物制剂及其用途。 药物形式提供活性化合物在粘膜上的增强的吸收。